Finance

From Zero to Audit-Ready: BrightIron Builds Finance Infrastructure for Deep Genomics

Strategic financial guidance that transformed fundraising readiness and extended runway by 8 months.

Introduction

Deep Genomics is a biotech startup using AI, RNA biology and automation to rethink how drugs are developed. As a growing company, they needed help building out their accounting processes and policies from the ground up—plus ongoing support to keep their books accurate and their financials in order. That’s where BrightIron came in. We helped lay the foundation for a finance function that could keep up with their innovation.

The Challenge

As an early-stage biotech company, Deep Genomics needed to build a solid financial foundation to support its growth and innovation. With no internal finance team in place, they required support setting up their accounting systems, implementing processes and controls, and ensuring their financial data was accurate and audit-ready. They were also preparing for their first annual external financial audit and needed expert guidance to get everything in shape.

Our Solutions

BrightIron came on board to handle Deep Genomics’ bookkeeping and accounting needs from the ground up. We implemented QuickBooks Online along with a tailored finance tech stack to streamline day-to-day financial operations.

To give the company better visibility into its finances, we developed and rolled out a customized chart of accounts, designed specifically to support strategic decision-making. Our team handled the accurate entry of all financial transactions and established clear financial processes and internal controls to ensure consistency and compliance.

When it came time for the company’s first annual external audit, BrightIron supported Deep Genomics every step of the way—ensuring they were fully prepared and that the process ran smoothly.

“After we raised our seed round it became clear that we needed more support with accounting and bookkeeping. The team at BrightIron quickly put in place the processes that we needed and has been a valuable partner ever since.”

Matt Cahill

VP, Finance & Business Operations, Deep Genomics

Companies We’ve Supported

Recent Blog Posts

The latest industry news, interviews, technologies, and resources.